Management of Moderate Atopic Dermatitis in Adolescents

Introduction to Treatment

For a 13-year-old with moderate atopic dermatitis, the American Academy of Dermatology recommends using low to medium potency topical corticosteroids such as fluticasone or mometasone applied once or twice daily to affected areas, with proactive twice-weekly application to previously affected areas to prevent relapses 1, 2, 3

The American Academy of Dermatology suggests that low to medium potency corticosteroids are the appropriate choice for moderate disease in adolescents, with specific recommended agents including fluticasone propionate and mometasone furoate 1, 2
For the face, neck, and skin folds, the American Academy of Pediatrics recommends using only low-potency corticosteroids such as hydrocortisone 1% to avoid skin atrophy, or considering topical calcineurin inhibitors as an alternative 2, 3

The American Academy of Dermatology advises applying the selected corticosteroid once or twice daily to active lesions during flares, and continuing for 3-7 days or until lesions significantly improve, then transitioning to proactive twice-weekly maintenance 1, 2
The proactive approach prevents relapses and has a steroid-sparing effect, and should be continued long-term to reduce flare frequency 1, 3

The American Academy of Pediatrics recommends applying fragrance-free emollients liberally and frequently, regardless of disease activity, as emollients have both short and long-term steroid-sparing effects 1, 2, 3

If bacterial superinfection develops, the American Academy of Dermatology suggests treating with flucloxacillin, and for suspected herpes simplex, initiating oral acyclovir immediately 2, 4, 5, 6

The American Academy of Pediatrics notes that adolescents have a lower risk of HPA axis suppression than younger children, but high or ultra-high potency steroids should still be avoided or used only for short periods in severe cases 2, 3
The American Academy of Dermatology recommends monitoring for signs of skin atrophy, striae, or telangiectasia with prolonged use, and educating patients on proper application technique and the difference between reactive and proactive therapy 1, 2

The American Academy of Dermatology advises against using high-potency or ultra-high-potency steroids as first-line for moderate disease, and avoiding potent steroids on the face, neck, or intertriginous areas 2, 3, 4
The American Academy of Pediatrics recommends not continuing daily application beyond 7 days without reassessment, and not abruptly stopping after prolonged daily use, instead transitioning to proactive twice-weekly maintenance 1, 2, 3

Triamcinolone 0.1% is classified as a mid-potency (Class IV) topical corticosteroid, making it appropriate for moderate eczema flares on the trunk and extremities, according to the American Academy of Dermatology 7
For treatment courses up to 4 weeks, mid-potency topical corticosteroids like triamcinolone 0.1% have strong safety evidence, with a low risk of skin atrophy (approximately 1% across studies), as reported by the Journal of the American Academy of Dermatology 7

Prescribe liberal amounts of fragrance-free emollients (200-400g per week for twice-daily application) to be used regardless of disease activity, as recommended by the BMJ 8
Dispense 454g jar of emollient (e.g., CeraVe, Cetaphil, or Eucerin cream) with instructions to apply liberally to entire body twice daily, with ongoing refills, as suggested by the BMJ 9

If bacterial superinfection develops, add flucloxacillin 250-500mg four times daily for 7-10 days, as recommended by the BMJ 8
If no improvement after 2 weeks, consider stepping up to a more potent corticosteroid (e.g., betamethasone valerate 0.1%) or refer to dermatology, according to the BMJ 8 and 9